Genetic risk for chronic fatigue syndrome

Description of the granted funding

The goal of this proposal is to understand underlying biological mechanisms behind chronic fatigue syndrome (CFS) and long-term symptoms from COVID-19 (LongCOVID) using genetics and epidemiology. A hallmark of CFS is debilitating fatigue, migrating pain, headache, fluctuating heart rate and dysautonomia. CFS diagnosis can follow infections or self-reported infection, and flu-like symptoms. Similarly, a characteristic in infection with SARS-CoV-2 is that some individuals with relatively mild infection develop long-term symptoms of severe fatigue, pain and dysautonomia similar to CFS. Currently, there is no cure and the treatment options are symptomatic. We will use genetic and epidemiology tools to explore the etiology of CFS and LongCOVID. The project has the potential to discover novel biological molecules, elucidate mechanisms from infections and autoimmunity on CFS and explore the disease burden from CFS and LongCOVID at the population level.
Show more

Starting year

2022

End year

2027

Granted funding

Hanna Ollila Orcid -palvelun logo
447 650 €

Related funding decisions

372129
Research costs of Academy Research Fellows(2025)
181 775 €
353812
Research costs of Academy Research Fellows(2022)
300 000 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Decision maker

Scientific Council for Biosciences, Health and the Environment
30.05.2022

Other information

Funding decision number

350181

Fields of science

Genetics, developmental biology, physiology

Research fields

Perinnöllisyystiede

Identified topics

public health, occupational health